The first ImmunoPrecise Antibodies trade was made in Q3 2021. Since then Ken Griffin bought shares five more times and sold shares on seven occasions. The investor sold all their shares in Q3 2024 and doesn't own any shares in ImmunoPrecise Antibodies anymore.